PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved a variation application from Pfizer (Malaysia) Sdn Bhd in relation to updating the shelf life of Covid-19 Comirnaty Concentrate for Dispersion for Injection vaccine.
The extension of the shelf life of COVID-19 vaccines has been carried out based on data from the results of vaccine stability tests by manufacturers holding .